

Name | Size/Type | Description | Date |
---|---|---|---|
Panitumumab + Irinotecan MdG consent | 116KB PDF | Panitumumab + Folfiri consent | 01 Dec 2020 |
Panitumumab + Oxaliplatin MdG (Folfox) consent | 117KB PDF | Panitumumab + Folfox consent | 01 Dec 2020 |
Panitumumab consent | 114KB PDF | Panitumumab consent | 07 Jun 2023 |
Pazopanib consent | 111KB PDF | Pazopanib consent | 21 Apr 2020 |
PCV Consent | 112KB PDF | PCV Consent | 21 Apr 2020 |
Pembrolizumab + Abraxane consent | 118KB PDF | Pembrolizumab + Abraxane consent | 29 Jul 2022 |
Pembrolizumab consent | 85KB PDF | Pembrolizumab consent | 30 Jan 2025 |
Pembrolizumab, Paclitaxel & Carboplatin consent | 142KB PDF | Pembrolizumab, Paclitaxel & Carboplatin consent | 28 Apr 2023 |
Pembrolizumab, Pemetrexed & Carboplatin consent | 117KB PDF | Pembrolizumab, Pemetrexed & Carboplatin consent | 21 Apr 2020 |
Pembrolizumab, Pemetrexed & Cisplatin consent | 117KB PDF | Pembrolizumab, Pemetrexed & Cisplatin consent | 21 Apr 2020 |
Pemetrexed & Carboplatin consent | 112KB PDF | Pemetrexed & Carboplatin consent | 21 Apr 2020 |
Pemetrexed & Cisplatin consent | 113KB PDF | Pemetrexed & Cisplatin consent | 21 Apr 2020 |
Pemetrexed consent | 111KB PDF | Pemetrexed consent | 21 Apr 2020 |
Pemigatinib consent | 114KB PDF | Pemigatinib consent | 02 Aug 2021 |
Pertuzumab & Trastuzumab (Phesgo) consent | 139KB PDF | pertuzumab + trastuzumab (phesgo) consent | 26 Feb 2021 |
Raltitrexed & Oxaliplatin consent | 113KB PDF | Raltitrexed & Oxaliplatin consent | 21 Apr 2020 |
Raltitrexed consent | 112KB PDF | Raltitrexed consent | 21 Apr 2020 |
Regorafenib consent | 111KB PDF | Regorafenib consent | 21 Apr 2020 |
Ribociclib consent | 112KB PDF | Ribociclib consent | 21 Apr 2020 |
Rucaparib consent | 103KB PDF | Rucaparib consent | 23 Sep 2024 |
Sacituzumab govitecan consent | 115KB PDF | Sacituzumab govitecan consent | 25 Feb 2022 |
Selpercatinib consent | 112KB PDF | Selpercatinib consent | 05 Jan 2023 |
Sorafenib consent | 110KB PDF | Sorafenib consent | 21 Apr 2020 |
Sotorasib consent | 112KB PDF | Sotorasib consent | 16 Dec 2021 |
Sunitinib consent | 111KB PDF | Sunitinib consent | 21 Apr 2020 |
T-Carbo-F consent | 117KB PDF | T-Carbo-F consent | 13 Apr 2021 |
Talazoparib consent | 107KB PDF | Talazoparib consent | 04 Apr 2024 |
Temozolomide consent | 111KB PDF | Temozolomide consent | 05 Jun 2020 |
Tepotinib consent | 112KB PDF | Tepotinib consent | 05 Oct 2021 |
Tepotinib consent | 112KB PDF | Tepotinib consent | 08 Oct 2021 |
All consent forms on this website are for the use of St Luke’s Cancer Alliance staff in respect of St Luke’s Cancer Alliance patients only.
For those who do not work within St Luke’s Cancer Alliance:
Use of this site and any information on it is at your own risk. We do not accept responsibility for the use of any information that may be set out on the website. You assume full responsibility for the use of the information. You may wish to take your own legal advice before using any of the consent forms.
Please note that the consent forms below are not tumour-specific; one consent form may be used to consent patients for more than one St Luke’s Alliance chemotherapy protocol which uses the same combination of chemotherapy.
These consent forms should act as an aide-memoire to health professionals and patients, by providing a check-list of the kind of information which patients should be offered, and by enabling the patient to have a written record of the main points discussed.
The relevant Macmillan leaflet(s) should also be provided to each patient before consent. In no way should written information given to the patient be regarded as a substitute for face-to-face discussions with the patient.
These consent forms are for solid tumour chemotherapy only, and are NOT to be used for chemo-radiotherapy regimens.